195 related articles for article (PubMed ID: 6196846)
1. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
2. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
3. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
5. Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Prinz RA; Marangos PJ
Am J Surg; 1983 Jan; 145(1):77-81. PubMed ID: 6295198
[TBL] [Abstract][Full Text] [Related]
6. Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours.
Grossmann M; Trautmann ME; Poertl S; Hoermann R; Berger P; Arnold R; Mann K
Eur J Clin Invest; 1994 Feb; 24(2):131-6. PubMed ID: 7515807
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadotropin and human placental lactogen in extragonadal tumors. An immunoperoxidase study of ten non-germ cell neoplasms.
Heyderman E; Chapman DV; Richardson TC; Calvert I; Rosen SW
Cancer; 1985 Dec; 56(11):2674-82. PubMed ID: 2413978
[TBL] [Abstract][Full Text] [Related]
8. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
Kanakis G; Kaltsas G
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
[TBL] [Abstract][Full Text] [Related]
9. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Iwase K; Kato K; Nagasaka A; Miura K; Kawase K; Miyakawa S; Tei T; Ohtani S; Inagaki M; Shinoda S
Gastroenterology; 1986 Sep; 91(3):576-80. PubMed ID: 3015709
[TBL] [Abstract][Full Text] [Related]
11. HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour.
Oberg K; Wide L; Boström H
Acta Med Scand; 1981; 210(3):231-3. PubMed ID: 6270988
[TBL] [Abstract][Full Text] [Related]
12. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy.
Kahn CR; Rosen SW; Weintraub BD; Fajans SS; Gorden P
N Engl J Med; 1977 Sep; 297(11):565-9. PubMed ID: 196194
[TBL] [Abstract][Full Text] [Related]
13. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
14. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.
Oberg K; Wide L
Acta Endocrinol (Copenh); 1981 Oct; 98(2):256-60. PubMed ID: 6117168
[TBL] [Abstract][Full Text] [Related]
15. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
16. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours.
Oberg K
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S17-25. PubMed ID: 22005113
[No Abstract] [Full Text] [Related]
17. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
Simpson S; Vinik AI; Marangos PJ; Lloyd RV
Cancer; 1984 Oct; 54(7):1364-9. PubMed ID: 6088026
[TBL] [Abstract][Full Text] [Related]
18. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies.
Friesen SR; Kimmel JR; Tomita T
Am J Surg; 1980 Jan; 139(1):61-72. PubMed ID: 6243207
[TBL] [Abstract][Full Text] [Related]
20. Biochemical diagnosis of gastroenteropancreatic endocrine tumors.
Tartaglia A; Bianchini S; Vezzadini P
Minerva Med; 2003 Feb; 94(1):1-7. PubMed ID: 12719697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
